Loading…
An integrative understanding of the large metabolic shifts induced by antibiotics in critical illness
Antibiotics are commonly used in the Intensive Care Unit (ICU); however, several studies showed that the impact of antibiotics to prevent infection, multi-organ failure, and death in the ICU is less clear than their benefit on course of infection in the absence of organ dysfunction. We characterized...
Saved in:
Published in: | Gut microbes 2021-01, Vol.13 (1), p.1993598-1993598 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c534t-1c80db718155059e8871564c133e273eb5f0e01bb03e75ca2f269b6527e6c39a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c534t-1c80db718155059e8871564c133e273eb5f0e01bb03e75ca2f269b6527e6c39a3 |
container_end_page | 1993598 |
container_issue | 1 |
container_start_page | 1993598 |
container_title | Gut microbes |
container_volume | 13 |
creator | Marfil-Sánchez, Andrea Zhang, Lu Alonso-Pernas, Pol Mirhakkak, Mohammad Mueller, Melinda Seelbinder, Bastian Ni, Yueqiong Santhanam, Rakesh Busch, Anne Beemelmanns, Christine Ermolaeva, Maria Bauer, Michael Panagiotou, Gianni |
description | Antibiotics are commonly used in the Intensive Care Unit (ICU); however, several studies showed that the impact of antibiotics to prevent infection, multi-organ failure, and death in the ICU is less clear than their benefit on course of infection in the absence of organ dysfunction. We characterized here the compositional and metabolic changes of the gut microbiome induced by critical illness and antibiotics in a cohort of 75 individuals in conjunction with 2,180 gut microbiome samples representing 16 different diseases. We revealed an "infection-vulnerable" gut microbiome environment present only in critically ill treated with antibiotics (ICU
+
). Feeding of Caenorhabditis elegans with Bifidobacterium animalis and Lactobacillus crispatus, species that expanded in ICU
+
patients, revealed a significant negative impact of these microbes on host viability and developmental homeostasis. These results suggest that antibiotic administration can dramatically impact essential functional activities in the gut related to immune responses more than critical illness itself, which might explain in part untoward effects of antibiotics in the critically ill. |
doi_str_mv | 10.1080/19490976.2021.1993598 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2599183207</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_aa87bc94a1fb48ea8392831d68f0aae0</doaj_id><sourcerecordid>2599183207</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-1c80db718155059e8871564c133e273eb5f0e01bb03e75ca2f269b6527e6c39a3</originalsourceid><addsrcrecordid>eNp9kU9v3CAQxa2qVROl-QitOPayWzDGwKVqFPVPpEi9tGc04LGXiIUUcKr99vV2N6vkEi6M3rz5zUivad4zumZU0U9Md5pq2a9b2rI105oLrV4153t9RbXqXp9q2Z81l6Xc0eV1naQ9f9uc8U5q3kp53uBVJD5WnDJU_4BkjgPmUiEOPk4kjaRukATIE5ItVrApeEfKxo-1LHPD7HAgdkcgVm99qt7tZeKyX0oIxIcQsZR3zZsRQsHL43_R_P729df1j9Xtz-8311e3Kyd4V1fMKTpYyRQTggqNSkkm-s4xzrGVHK0YKVJmLeUohYN2bHtte9FK7B3XwC-amwN3SHBn7rPfQt6ZBN78F1KeDOTlsoAGQEnrdAdstJ1CUFy3irOhVyMFQLqwPh9Y97Pd4uAw1gzhGfR5J_qNmdKDUT3tuBYL4OMRkNOfGUs1W18chgAR01xMK7RmirdULlZxsLqcSsk4ntYwavaJm8fEzT5xc0x8mfvw9MbT1GO-i-HLweDjmPIW_qYcBlNhF1IeM0Tni-Ev7_gHvI-8YQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2599183207</pqid></control><display><type>article</type><title>An integrative understanding of the large metabolic shifts induced by antibiotics in critical illness</title><source>Taylor & Francis Open Access Journals</source><source>PubMed Central</source><creator>Marfil-Sánchez, Andrea ; Zhang, Lu ; Alonso-Pernas, Pol ; Mirhakkak, Mohammad ; Mueller, Melinda ; Seelbinder, Bastian ; Ni, Yueqiong ; Santhanam, Rakesh ; Busch, Anne ; Beemelmanns, Christine ; Ermolaeva, Maria ; Bauer, Michael ; Panagiotou, Gianni</creator><creatorcontrib>Marfil-Sánchez, Andrea ; Zhang, Lu ; Alonso-Pernas, Pol ; Mirhakkak, Mohammad ; Mueller, Melinda ; Seelbinder, Bastian ; Ni, Yueqiong ; Santhanam, Rakesh ; Busch, Anne ; Beemelmanns, Christine ; Ermolaeva, Maria ; Bauer, Michael ; Panagiotou, Gianni</creatorcontrib><description>Antibiotics are commonly used in the Intensive Care Unit (ICU); however, several studies showed that the impact of antibiotics to prevent infection, multi-organ failure, and death in the ICU is less clear than their benefit on course of infection in the absence of organ dysfunction. We characterized here the compositional and metabolic changes of the gut microbiome induced by critical illness and antibiotics in a cohort of 75 individuals in conjunction with 2,180 gut microbiome samples representing 16 different diseases. We revealed an "infection-vulnerable" gut microbiome environment present only in critically ill treated with antibiotics (ICU
+
). Feeding of Caenorhabditis elegans with Bifidobacterium animalis and Lactobacillus crispatus, species that expanded in ICU
+
patients, revealed a significant negative impact of these microbes on host viability and developmental homeostasis. These results suggest that antibiotic administration can dramatically impact essential functional activities in the gut related to immune responses more than critical illness itself, which might explain in part untoward effects of antibiotics in the critically ill.</description><identifier>ISSN: 1949-0976</identifier><identifier>EISSN: 1949-0984</identifier><identifier>DOI: 10.1080/19490976.2021.1993598</identifier><identifier>PMID: 34793277</identifier><language>eng</language><publisher>United States: Taylor & Francis</publisher><subject>Animals ; Anti-Bacterial Agents - adverse effects ; antibiotics ; Bacteria - classification ; Bacteria - drug effects ; Bacteria - metabolism ; Bacteria - pathogenicity ; Bile Acids and Salts - metabolism ; Candida - classification ; Candida - drug effects ; Candida - metabolism ; Candida - pathogenicity ; Critical Illness ; Drug Resistance, Fungal - drug effects ; Fatty Acids, Volatile - metabolism ; Gastrointestinal Microbiome - drug effects ; Gut microbiota ; Humans ; Infections - microbiology ; intensive care unit ; Intensive Care Units ; ITS2 ; Metabolome - drug effects ; metabolomics ; metagenomics ; Moths ; Research Paper</subject><ispartof>Gut microbes, 2021-01, Vol.13 (1), p.1993598-1993598</ispartof><rights>2021 The Author(s). Published with license by Taylor & Francis Group, LLC. 2021</rights><rights>2021 The Author(s). Published with license by Taylor & Francis Group, LLC. 2021 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-1c80db718155059e8871564c133e273eb5f0e01bb03e75ca2f269b6527e6c39a3</citedby><cites>FETCH-LOGICAL-c534t-1c80db718155059e8871564c133e273eb5f0e01bb03e75ca2f269b6527e6c39a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604395/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604395/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27502,27924,27925,53791,53793,59143,59144</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34793277$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marfil-Sánchez, Andrea</creatorcontrib><creatorcontrib>Zhang, Lu</creatorcontrib><creatorcontrib>Alonso-Pernas, Pol</creatorcontrib><creatorcontrib>Mirhakkak, Mohammad</creatorcontrib><creatorcontrib>Mueller, Melinda</creatorcontrib><creatorcontrib>Seelbinder, Bastian</creatorcontrib><creatorcontrib>Ni, Yueqiong</creatorcontrib><creatorcontrib>Santhanam, Rakesh</creatorcontrib><creatorcontrib>Busch, Anne</creatorcontrib><creatorcontrib>Beemelmanns, Christine</creatorcontrib><creatorcontrib>Ermolaeva, Maria</creatorcontrib><creatorcontrib>Bauer, Michael</creatorcontrib><creatorcontrib>Panagiotou, Gianni</creatorcontrib><title>An integrative understanding of the large metabolic shifts induced by antibiotics in critical illness</title><title>Gut microbes</title><addtitle>Gut Microbes</addtitle><description>Antibiotics are commonly used in the Intensive Care Unit (ICU); however, several studies showed that the impact of antibiotics to prevent infection, multi-organ failure, and death in the ICU is less clear than their benefit on course of infection in the absence of organ dysfunction. We characterized here the compositional and metabolic changes of the gut microbiome induced by critical illness and antibiotics in a cohort of 75 individuals in conjunction with 2,180 gut microbiome samples representing 16 different diseases. We revealed an "infection-vulnerable" gut microbiome environment present only in critically ill treated with antibiotics (ICU
+
). Feeding of Caenorhabditis elegans with Bifidobacterium animalis and Lactobacillus crispatus, species that expanded in ICU
+
patients, revealed a significant negative impact of these microbes on host viability and developmental homeostasis. These results suggest that antibiotic administration can dramatically impact essential functional activities in the gut related to immune responses more than critical illness itself, which might explain in part untoward effects of antibiotics in the critically ill.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>antibiotics</subject><subject>Bacteria - classification</subject><subject>Bacteria - drug effects</subject><subject>Bacteria - metabolism</subject><subject>Bacteria - pathogenicity</subject><subject>Bile Acids and Salts - metabolism</subject><subject>Candida - classification</subject><subject>Candida - drug effects</subject><subject>Candida - metabolism</subject><subject>Candida - pathogenicity</subject><subject>Critical Illness</subject><subject>Drug Resistance, Fungal - drug effects</subject><subject>Fatty Acids, Volatile - metabolism</subject><subject>Gastrointestinal Microbiome - drug effects</subject><subject>Gut microbiota</subject><subject>Humans</subject><subject>Infections - microbiology</subject><subject>intensive care unit</subject><subject>Intensive Care Units</subject><subject>ITS2</subject><subject>Metabolome - drug effects</subject><subject>metabolomics</subject><subject>metagenomics</subject><subject>Moths</subject><subject>Research Paper</subject><issn>1949-0976</issn><issn>1949-0984</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>DOA</sourceid><recordid>eNp9kU9v3CAQxa2qVROl-QitOPayWzDGwKVqFPVPpEi9tGc04LGXiIUUcKr99vV2N6vkEi6M3rz5zUivad4zumZU0U9Md5pq2a9b2rI105oLrV4153t9RbXqXp9q2Z81l6Xc0eV1naQ9f9uc8U5q3kp53uBVJD5WnDJU_4BkjgPmUiEOPk4kjaRukATIE5ItVrApeEfKxo-1LHPD7HAgdkcgVm99qt7tZeKyX0oIxIcQsZR3zZsRQsHL43_R_P729df1j9Xtz-8311e3Kyd4V1fMKTpYyRQTggqNSkkm-s4xzrGVHK0YKVJmLeUohYN2bHtte9FK7B3XwC-amwN3SHBn7rPfQt6ZBN78F1KeDOTlsoAGQEnrdAdstJ1CUFy3irOhVyMFQLqwPh9Y97Pd4uAw1gzhGfR5J_qNmdKDUT3tuBYL4OMRkNOfGUs1W18chgAR01xMK7RmirdULlZxsLqcSsk4ntYwavaJm8fEzT5xc0x8mfvw9MbT1GO-i-HLweDjmPIW_qYcBlNhF1IeM0Tni-Ev7_gHvI-8YQ</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Marfil-Sánchez, Andrea</creator><creator>Zhang, Lu</creator><creator>Alonso-Pernas, Pol</creator><creator>Mirhakkak, Mohammad</creator><creator>Mueller, Melinda</creator><creator>Seelbinder, Bastian</creator><creator>Ni, Yueqiong</creator><creator>Santhanam, Rakesh</creator><creator>Busch, Anne</creator><creator>Beemelmanns, Christine</creator><creator>Ermolaeva, Maria</creator><creator>Bauer, Michael</creator><creator>Panagiotou, Gianni</creator><general>Taylor & Francis</general><general>Taylor & Francis Group</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210101</creationdate><title>An integrative understanding of the large metabolic shifts induced by antibiotics in critical illness</title><author>Marfil-Sánchez, Andrea ; Zhang, Lu ; Alonso-Pernas, Pol ; Mirhakkak, Mohammad ; Mueller, Melinda ; Seelbinder, Bastian ; Ni, Yueqiong ; Santhanam, Rakesh ; Busch, Anne ; Beemelmanns, Christine ; Ermolaeva, Maria ; Bauer, Michael ; Panagiotou, Gianni</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-1c80db718155059e8871564c133e273eb5f0e01bb03e75ca2f269b6527e6c39a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>antibiotics</topic><topic>Bacteria - classification</topic><topic>Bacteria - drug effects</topic><topic>Bacteria - metabolism</topic><topic>Bacteria - pathogenicity</topic><topic>Bile Acids and Salts - metabolism</topic><topic>Candida - classification</topic><topic>Candida - drug effects</topic><topic>Candida - metabolism</topic><topic>Candida - pathogenicity</topic><topic>Critical Illness</topic><topic>Drug Resistance, Fungal - drug effects</topic><topic>Fatty Acids, Volatile - metabolism</topic><topic>Gastrointestinal Microbiome - drug effects</topic><topic>Gut microbiota</topic><topic>Humans</topic><topic>Infections - microbiology</topic><topic>intensive care unit</topic><topic>Intensive Care Units</topic><topic>ITS2</topic><topic>Metabolome - drug effects</topic><topic>metabolomics</topic><topic>metagenomics</topic><topic>Moths</topic><topic>Research Paper</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marfil-Sánchez, Andrea</creatorcontrib><creatorcontrib>Zhang, Lu</creatorcontrib><creatorcontrib>Alonso-Pernas, Pol</creatorcontrib><creatorcontrib>Mirhakkak, Mohammad</creatorcontrib><creatorcontrib>Mueller, Melinda</creatorcontrib><creatorcontrib>Seelbinder, Bastian</creatorcontrib><creatorcontrib>Ni, Yueqiong</creatorcontrib><creatorcontrib>Santhanam, Rakesh</creatorcontrib><creatorcontrib>Busch, Anne</creatorcontrib><creatorcontrib>Beemelmanns, Christine</creatorcontrib><creatorcontrib>Ermolaeva, Maria</creatorcontrib><creatorcontrib>Bauer, Michael</creatorcontrib><creatorcontrib>Panagiotou, Gianni</creatorcontrib><collection>Taylor & Francis Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Gut microbes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marfil-Sánchez, Andrea</au><au>Zhang, Lu</au><au>Alonso-Pernas, Pol</au><au>Mirhakkak, Mohammad</au><au>Mueller, Melinda</au><au>Seelbinder, Bastian</au><au>Ni, Yueqiong</au><au>Santhanam, Rakesh</au><au>Busch, Anne</au><au>Beemelmanns, Christine</au><au>Ermolaeva, Maria</au><au>Bauer, Michael</au><au>Panagiotou, Gianni</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An integrative understanding of the large metabolic shifts induced by antibiotics in critical illness</atitle><jtitle>Gut microbes</jtitle><addtitle>Gut Microbes</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>13</volume><issue>1</issue><spage>1993598</spage><epage>1993598</epage><pages>1993598-1993598</pages><issn>1949-0976</issn><eissn>1949-0984</eissn><abstract>Antibiotics are commonly used in the Intensive Care Unit (ICU); however, several studies showed that the impact of antibiotics to prevent infection, multi-organ failure, and death in the ICU is less clear than their benefit on course of infection in the absence of organ dysfunction. We characterized here the compositional and metabolic changes of the gut microbiome induced by critical illness and antibiotics in a cohort of 75 individuals in conjunction with 2,180 gut microbiome samples representing 16 different diseases. We revealed an "infection-vulnerable" gut microbiome environment present only in critically ill treated with antibiotics (ICU
+
). Feeding of Caenorhabditis elegans with Bifidobacterium animalis and Lactobacillus crispatus, species that expanded in ICU
+
patients, revealed a significant negative impact of these microbes on host viability and developmental homeostasis. These results suggest that antibiotic administration can dramatically impact essential functional activities in the gut related to immune responses more than critical illness itself, which might explain in part untoward effects of antibiotics in the critically ill.</abstract><cop>United States</cop><pub>Taylor & Francis</pub><pmid>34793277</pmid><doi>10.1080/19490976.2021.1993598</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1949-0976 |
ispartof | Gut microbes, 2021-01, Vol.13 (1), p.1993598-1993598 |
issn | 1949-0976 1949-0984 |
language | eng |
recordid | cdi_proquest_miscellaneous_2599183207 |
source | Taylor & Francis Open Access Journals; PubMed Central |
subjects | Animals Anti-Bacterial Agents - adverse effects antibiotics Bacteria - classification Bacteria - drug effects Bacteria - metabolism Bacteria - pathogenicity Bile Acids and Salts - metabolism Candida - classification Candida - drug effects Candida - metabolism Candida - pathogenicity Critical Illness Drug Resistance, Fungal - drug effects Fatty Acids, Volatile - metabolism Gastrointestinal Microbiome - drug effects Gut microbiota Humans Infections - microbiology intensive care unit Intensive Care Units ITS2 Metabolome - drug effects metabolomics metagenomics Moths Research Paper |
title | An integrative understanding of the large metabolic shifts induced by antibiotics in critical illness |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A05%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20integrative%20understanding%20of%20the%20large%20metabolic%20shifts%20induced%20by%20antibiotics%20in%20critical%20illness&rft.jtitle=Gut%20microbes&rft.au=Marfil-S%C3%A1nchez,%20Andrea&rft.date=2021-01-01&rft.volume=13&rft.issue=1&rft.spage=1993598&rft.epage=1993598&rft.pages=1993598-1993598&rft.issn=1949-0976&rft.eissn=1949-0984&rft_id=info:doi/10.1080/19490976.2021.1993598&rft_dat=%3Cproquest_cross%3E2599183207%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c534t-1c80db718155059e8871564c133e273eb5f0e01bb03e75ca2f269b6527e6c39a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2599183207&rft_id=info:pmid/34793277&rfr_iscdi=true |